Literature DB >> 21835931

Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia.

Raymond K Kudej1, Mathew Fasano, Xin Zhao, Gary D Lopaschuk, Susan K Fischer, Dorothy E Vatner, Stephen F Vatner, E Douglas Lewandowski.   

Abstract

AIMS: Although a major mechanism for cardioprotection is altered metabolism, little is known regarding metabolic changes in ischaemic preconditioning and subsequent ischaemia. Our objective was to examine the effects of the second window of preconditioning (SWOP), the delayed phase of preconditioning against infarction and stunning, on long-chain free fatty acid (LCFA) oxidation during ischaemia in chronically instrumented, conscious pigs. METHODS AND
RESULTS: We studied three groups: (i) normal baseline perfusion (n = 5); (ii) coronary artery stenosis (CAS; n = 5); (iii) CAS 24 h following 2 × 10 min coronary occlusions and 10 min reperfusion (n = 7). Ischaemia was induced by a left anterior descending (LAD) stenosis (40% flow reduction) for 90 min, dropping systolic wall thickening by 72%. LCFA oxidation was assessed following LAD infusion of (13)C palmitate, i.e. during control or stenosis, by in vitro nuclear magnetic resonance of the sampled myocardium. Stenosis reduced subendocardial blood flow subendocardially, but not subepicardial, yet induced transmural reductions in LCFA oxidation and increased non-oxidative glycolysis. During stenosis, preconditioned hearts showed normalized contributions of LCFA to oxidative ATP synthesis, despite increased lactate accumulation. SWOP induced a shift towards LCFA oxidation during stenosis, despite increased malonyl-CoA, and marked protection of contractile function with a significant improvement in systolic wall thickening.
CONCLUSION: Thus, the second window of preconditioning normalized oxidative metabolism of LCFA during subsequent ischaemia despite elevated non-oxidative glycolysis and malonyl-CoA and was linked to protection of regional contractile function resulting in improved mechanical performance. Interestingly, the metabolic responses occurred transmurally while ischaemia was restricted solely to the subendocardium.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835931      PMCID: PMC3211973          DOI: 10.1093/cvr/cvr215

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  50 in total

Review 1.  Metabolic mechanisms associated with antianginal therapy.

Authors:  E D Lewandowski
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

2.  Substrate-dependent proton load and recovery of stunned hearts during pyruvate dehydrogenase stimulation.

Authors:  J L Griffin; L T White; E D Lewandowski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

3.  Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction.

Authors:  E Douglas Lewandowski; Raymond K Kudej; Lawrence T White; J Michael O'Donnell; Stephen F Vatner
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

4.  High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation.

Authors:  Que Liu; John C Docherty; John C T Rendell; Alexander S Clanachan; Gary D Lopaschuk
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

5.  Nitric oxide, an important regulator of perfusion-contraction matching in conscious pigs.

Authors:  R K Kudej; S J Kim; Y T Shen; J B Jackson; A B Kudej; G P Yang; S P Bishop; S F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

6.  Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs.

Authors:  Raymond K Kudej; Lawrence T White; Amelia B Kudej; Stephen F Vatner; E Douglas Lewandowski
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

7.  Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase.

Authors:  H Tong; W Chen; R E London; E Murphy; C Steenbergen
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

Review 8.  Myocardial fatty acid metabolism in health and disease.

Authors:  Gary D Lopaschuk; John R Ussher; Clifford D L Folmes; Jagdip S Jaswal; William C Stanley
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection.

Authors:  Yasuhiro Nishino; Tetsuji Miura; Takayuki Miki; Jun Sakamoto; Yuichi Nakamura; Yoshihiro Ikeda; Hironori Kobayashi; Kazuaki Shimamoto
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

Review 10.  Malonyl CoA control of fatty acid oxidation in the ischemic heart.

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Mol Cell Cardiol       Date:  2002-09       Impact factor: 5.000

View more
  7 in total

Review 1.  Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Authors:  Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang
Journal:  Circ Res       Date:  2016-03-24       Impact factor: 17.367

2.  Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy.

Authors:  E Douglas Lewandowski; Susan K Fischer; Matthew Fasano; Natasha H Banke; Lori A Walker; Alda Huqi; Xuerong Wang; Gary D Lopaschuk; J Michael O'Donnell
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

3.  A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.

Authors:  Claudio A Bravo; Dorothy E Vatner; Ronald Pachon; Jie Zhang; Stephen F Vatner
Journal:  J Pharmacol Exp Ther       Date:  2016-03-03       Impact factor: 4.030

4.  Metabolomic analysis of two different models of delayed preconditioning.

Authors:  Claudio Bravo; Raymond K Kudej; Chujun Yuan; Seonghun Yoon; Hui Ge; Ji Yeon Park; Bin Tian; William C Stanley; Stephen F Vatner; Dorothy E Vatner; Lin Yan
Journal:  J Mol Cell Cardiol       Date:  2012-11-02       Impact factor: 5.000

5.  Secreted frizzled protein 3 is a novel cardioprotective mechanism unique to the clinically relevant fourth window of ischemic preconditioning.

Authors:  Dorothy E Vatner; Jie Zhang; Xin Zhao; Lin Yan; Raymond Kudej; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-18       Impact factor: 4.733

6.  Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.

Authors:  Lars C Gormsen; Mads Svart; Henrik Holm Thomsen; Esben Søndergaard; Mikkel H Vendelbo; Nana Christensen; Lars Poulsen Tolbod; Hendrik Johannes Harms; Roni Nielsen; Henrik Wiggers; Niels Jessen; Jakob Hansen; Hans Erik Bøtker; Niels Møller
Journal:  J Am Heart Assoc       Date:  2017-02-27       Impact factor: 5.501

7.  The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases.

Authors:  Phing-How Lou; Eliana Lucchinetti; Liyan Zhang; Andreas Affolter; Marcus C Schaub; Manoj Gandhi; Martin Hersberger; Blair E Warren; Hélène Lemieux; Hany F Sobhi; Alexander S Clanachan; Michael Zaugg
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.